Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MediPharm LabsSTU:MLZ -1.09% Quick Ratio is 1.76 as of Jun. 2026, which is 28% below its 10-year median of 2.45. The stock has 4 warning signs investors should review. Among 995 Drug Manufacturers companies, MediPharm Labs ranks better than 60.1% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. MediPharm Labs's quick ratio for the quarter that ended in Jun. 2026 was 1.76.
MediPharm Labs has a quick ratio of 1.76. It generally indicates good short-term financial strength.
The historical rank and industry rank for MediPharm Labs's Quick Ratio or its related term are showing as below:
STU:MLZ'
s Quick Ratio Range Over the Past 10 Years
Min: 0.66 Med: 2.45 Max: 64
Current: 1.76
During the past 9 years, MediPharm Labs's highest Quick Ratio was 64.00. The lowest was 0.66. And the median was 2.45.
STU:MLZ's Quick Ratio is ranked better than 60.1% of 995
companies
in the Drug Manufacturers industry
Industry Median: 1.42
vs STU:MLZ: 1.76
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
MediPharm Labs Quick Ratio Related Terms
MediPharm Labs Quick Ratio Historical Data
* Premium members only.
The historical data trend for MediPharm Labs's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MediPharm Labs Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's Quick Ratio distribution charts can be found below:
* The bar in red indicates where MediPharm Labs's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
MediPharm Labs's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MediPharm Labs (STU:MLZ) has a Quick Ratio of 1.76 as of Jun. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on MediPharm Labs and its competitors. This is 28% below median its historical median of 2.45. Over the past decade, MediPharm Labs' Quick Ratio has ranged from 0.66 to 64.00. According to the industry distribution chart, MediPharm Labs ranks #397 out of 995 companies in the Drug Manufacturers industry, placing it in the top 39.9%.
Is MediPharm Labs' Quick Ratio too high?
MediPharm Labs' current Quick Ratio of 1.76 is 28% below median its 10-year median of 2.45. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 64.00. The Drug Manufacturers industry median Quick Ratio is 1.42. MediPharm Labs' value of 1.76 is 23.9% above this industry median. Based on the distribution chart, MediPharm Labs ranks #397 out of 995 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does MediPharm Labs' Quick Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, MediPharm Labs ranks #397 out of 995 companies for Quick Ratio. This puts MediPharm Labs in the upper half of its industry. The industry median Quick Ratio is 1.42. MediPharm Labs' value of 1.76 is 23.9% above this benchmark. Historically, MediPharm Labs' own Quick Ratio has ranged from 0.66 to 64.00 over the past decade. While the company's 10-year median is 2.45 vs. the industry median of 1.42, MediPharm Labs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.42, based on 995 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MediPharm Labs's current Quick Ratio of 1.76 is 23.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on MediPharm Labs and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MediPharm Labs's current Quick Ratio is 1.76, which is 28% below median its own 10-year median of 2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediPharm Labs stock overvalued right now?
Based on GuruFocus' analysis, MediPharm Labs (STU:MLZ) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.04, compared to a current price of €0.05 — trading 13.8% above its estimated fair value. The current Quick Ratio is 1.76, which is 28% below median its 10-year median of 2.45 and 23.9% above the Drug Manufacturers industry median of 1.42. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For MediPharm Labs (STU:MLZ), the current Quick Ratio is 1.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MediPharm Labs Corp and its subsidiaries produce cannabis, purified and pharmaceutical-like cannabis extracts, related derivative products, and cannabis-related medical information and services. Its operating subsidiaries hold cultivation, standard processing, and sale licences under the Cannabis Act (Canada), allowing the cultivation, sale, and distribution of cannabis oil, extracts, edibles, topicals, dried and fresh cannabis, and derivatives to authorized purchasers. Its subsidiary provides clinic services to Canadian patients requiring medical cannabis education and prescriptions. The company operates in one reportable segment, the production and sales of cannabis flower, and generates maximum revenue from Canada, with additional international sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MLZ has been successfully added to your 
